Earnings History Data for scPharmaceuticals Inc. (SCPH) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
scPharmaceuticals Inc.
scPharmaceuticals, Inc., is a biopharmaceutical company. It engaged in developing pharmaceutical products for subcutaneous delivery. The Company's pipeline programs include: scFurosemide lead product candidate, Furoscix, consists of its proprietary subcutaneous formulation of furosemide delivered via sc2Wear Infusor for diuresis in heart failure patients outside of the acute care setting. scPharmaceuticals, Inc., is based in BURLINGTON, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-03-2024 | AH | SCPH | scPharmaceuticals Inc. | 189.34 | -0.35 | -0.48 | -0.30 | scPharmaceuticals GAAP EPS of -$0.35 beats by $0.07, revenue of $6.1M beats by $0.33M [3/13/2024 4:06 PM] |
5.30 | -0.14 (-2.57%) |
5.65 | 0.21 (3.86%) |
4.63 - 12.75 | 524,130 | 250,000 | 1,470 | ||
| 08-11-2023 | AH | SCPH | scPharmaceuticals Inc. | 189.68 | -0.41 | -0.36 | -0.37 | scPharmaceuticals GAAP EPS of -$0.41 misses by $0.05, revenue of $3.8M beats by $0.38M [11/8/2023 4:03 PM] |
4.70 | -0.45 (-8.74%) |
5.05 | -0.10 (-1.94%) |
4.63 - 12.75 | 1,083,472 | 230,000 | 12,738 | ||
| 10-08-2023 | AH | SCPH | scPharmaceuticals Inc. | 281.86 | -0.36 | -0.37 | -0.35 | scPharmaceuticals GAAP EPS of -$0.36 beats by $0.01, revenue of $1.63M beats by $0.01M [8/10/2023 4:10 PM] |
7.86 | 0.11 (1.35%) |
7.51 | -0.24 (-3.10%) |
3.68 - 12.75 | 613,386 | 320,000 | 2,869 | ||
| 10-05-2023 | AH | 4:05 PM ET (May 10) |
SCPH | scPharmaceuticals Inc. | 401.69 | -0.30 | -0.36 | -0.28 | scPharmaceuticals GAAP EPS of -$0.28 beats by $0.08, revenue of $2.1M beats by $0.53M [5/10/2023 4:20 PM] |
11.18 | -0.18 (-1.63%) |
12.25 | 0.89 (7.83%) |
3.68 - 12.75 | 604,925 | 240,000 | 1,574 | |
| 22-03-2023 | AH | 4:05 PM ET (Mar 22) |
SCPH | scPharmaceuticals Inc. | 275.84 | -0.30 | -0.42 | -0.27 | scPharmaceuticals GAAP EPS of -$0.27 beats by $0.12 [3/22/2023 4:27 PM] |
8.64 | 1.72 (24.86%) |
6.92 | 0.0 (0.00%) |
3.68 - 10.38 | 840,198 | 270,000 | 293 | |
| 09-11-2022 | AH | 4:00 PM ET (Nov 9) |
SCPH | scPharmaceuticals Inc. | 156.74 | -0.37 | -0.41 | -0.24 | scPharmaceuticals GAAP EPS of -$0.37, guidance lowered [11/9/2022 4:17 PM] |
6.01 | 0.63 (11.71%) |
5.80 | 0.42 (7.81%) |
3.48 - 7.09 | 741,787 | 120,000 | 2,402 | |
| 09-08-2022 | PM | 7:10 AM ET (Aug 9) |
SCPH | scPharmaceuticals | 140.00 | -0.35 | -0.32 | 0.00 | scPharmaceuticals GAAP EPS of -$0.35 misses by $0.05 [8/9/2022 8:35 AM] |
5.59 | 0.24 (4.40%) |
0.0 | 0.0 (0.00%) |
3.48 - 7.24 | 75,443 | 40,000 | 0 | |
| 16-05-2022 | PM | 7:00 AM ET (May 16) |
SCPH | scPharmaceuticals | 120.00 | -0.28 | -0.31 | 0.00 | scPharmaceuticals GAAP EPS of -$0.26 [5/16/2022 8:58 AM] |
4.71 | 0.27 (6.08%) |
4.60 | 0.16 (3.60%) |
3.48 - 7.28 | 31,081 | 20,000 | 514 | |
|
||||||||||||||||||
| 09-11-2021 | PM | SCPH | scPharmaceuticals | 166.00 | -0.24 | -0.32 | 0.00 | scPharmaceuticals EPS misses by $0.01 [11/9/2021 7:51 AM] |
6.05 | -0.29 (-4.57%) |
0.0 | 0.0 (0.00%) |
4.75 - 9.64 | 154,834 | 50,000 | 0 | ||
| 11-08-2021 | PM | SCPH | Scpharmaceuticals, Inc. | 160.00 | -0.26 | -0.30 | 0.00 | scPharmaceuticals EPS misses by $0.06 [8/11/2021 7:26 AM] |
5.68 | 0.14 (2.53%) |
0.0 | 0.0 (0.00%) |
5.06 - 9.64 | 35,833 | 50,000 | 0 | ||
| 12-05-2021 | PM | SCPH | scPharmaceuticals Inc. | 164.41 | -0.26 | -0.31 | -0.35 | scPharmaceuticals EPS misses by $0.05 [5/12/2021 8:25 AM] |
5.78 | -0.11 (-1.87%) |
0.0 | 0.0 (0.00%) |
5.06 - 11.99 | 36,574 | 90,000 | 0 | ||
| 23-03-2021 | PM | 7:00 AM ET (Mar 23) |
SCPH | scPharmaceuticals Inc. | 194.24 | -0.28 | -0.36 | -0.58 | scPharmaceuticals EPS misses by $0.22 [3/23/2021 7:32 AM] |
6.90 | -0.18 (-2.54%) |
0.0 | 0.0 (0.00%) |
5.00 - 11.99 | 46,489 | 80,000 | 0 | |
| 16-11-2020 | PM | SCPH | scPharmaceuticals Inc. | 248.07 | -0.33 | -0.38 | -0.33 | scPharmaceuticals EPS beats by $0.05 [11/16/2020 7:18 AM] |
9.16 | -0.10 (-1.08%) |
9.41 | 0.0 (0.00%) |
4.01 - 11.99 | 51,857 | 39,016 | 926 | ||
|
|
||||||||||||||||||
| 13-08-2020 | PM | SCPH | scPharmaceuticals Inc. | 216.20 | -0.36 | -0.43 | -0.39 | scPharmaceuticals EPS beats by $0.03 [8/13/2020 7:14 AM] |
8.38 | 0.30 (3.71%) |
0.0 | 0.0 (0.00%) |
4.01 - 11.99 | 23,565 | 60,639 | 0 | ||
|
|
||||||||||||||||||
| 12-05-2020 | PM | 7:00 AM ET (May 12) |
SCPH | scPharmaceuticals Inc. | 229.96 | -0.35 | -0.54 | -0.47 | scPharmaceuticals EPS beats by $0.19 [5/12/2020 7:08 AM] |
9.38 | -1.14 (-10.84%) |
0.0 | 0.0 (0.00%) |
2.78 - 11.99 | 66,714 | 61,127 | 0 | |
|
|
||||||||||||||||||